ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Alkido Pharma Inc

Alkido Pharma Inc (AIKI)

3.56
0.00
( 0.00% )
Updated: 18:00:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

AIKI News

Official News Only

AIKI Discussion

View Posts
Viewmont Viewmont 2 years ago
Got it thanks!
πŸ‘οΈ0
Viewmont Viewmont 2 years ago
Hi, I haven't been following AIKI for a while, just noticed its not trading, checked TDA / google with no result, did the ticker change or not public anymore after company bought shares? Thanks!
πŸ‘οΈ0
db101 db101 2 years ago
More insider shares purchased today…
πŸ‘οΈ0
db101 db101 2 years ago
More insider shares purchased…
πŸ‘οΈ0
db101 db101 2 years ago
AIKI looks to be headed back to 7…
πŸ‘οΈ0
db101 db101 2 years ago
More insider shares purchased…
πŸ‘οΈ0
db101 db101 2 years ago
A positive week… up 3.11%
πŸ‘οΈ0
db101 db101 2 years ago
…more shares purchased by the CEO
πŸ‘οΈ0
db101 db101 2 years ago
…AIKI seems to be getting its legs
πŸ‘οΈ0
db101 db101 2 years ago
AIKI is undervalued…
πŸ‘οΈ0
db101 db101 2 years ago
AIKI is ready…
πŸ‘οΈ0
db101 db101 2 years ago
The Company reported that on October 5, 2022, the Company purchased 10,500 shares of common stock at $7.0679 per share.
πŸ‘οΈ0
db101 db101 2 years ago
The Company reported that on October 4, 2022, the Company purchased 38,035 shares of common stock at $6.99 per share. Anthony Hayes, CEO of AIkido stated, "We believe the Company stock continues to be undervalued and we are using this opportunity to enhance shareholder value by reducing the amount of stock that is outstanding."
πŸ‘οΈ0
db101 db101 2 years ago
AIKI is buying more shares… 45k
πŸ‘οΈ0
ANTI-BAGHOLDER ANTI-BAGHOLDER 3 years ago
Shalom Auerbach board member on AMRR doesn’t mess around.



Shalom Auerbach, a significant stockholder of AIkido Pharma Inc. (NASDAQ: AIKI) beneficially owning approximately 3.4% of its common stock, today issued the following letter to members of the AIkido Pharma Inc. Board of Directors:

https://www.streetinsider.com/dr/news.php?id=20187179&gfv=1
πŸ‘οΈ0
PStockPickz PStockPickz 3 years ago
https://www.prnewswire.com/news-releases/aikido-pharma-secures-interest-in-electric-truck-maker-tevva-motors-ltd-301386841.html
πŸ‘οΈ0
PStockPickz PStockPickz 3 years ago
Averaging in some .48s
πŸ‘οΈ0
PStockPickz PStockPickz 3 years ago
Snagging some 50s
πŸ‘οΈ0
RNsidersbuying RNsidersbuying 3 years ago
AIkido Pharma announces $3M share repurchase program

https://ih.advfn.com/stock-market/NASDAQ/alkido-pharma-AIKI/stock-news/87087386/aikido-pharma-announces-3m-share-repurchase-progr
πŸ‘οΈ0
urge2surge urge2surge 3 years ago
Classic dog pile here. I'm out and won't be back.
πŸ‘οΈ0
RNsidersbuying RNsidersbuying 3 years ago
AIKI .47 - So, outsiders have sold this company's stock down to less than .50-on-the-dollar and insiders aren't filing Form-4-Buys by the truckload? How can management EVER promote it's own stock again when they show no interest in less than .50-on-the-dollar?

And what would be management's risk be in buying here at less than .50-on-the-dollar? It goes down to .25-on-the-dollar...whoa-is-me
πŸ‘οΈ0
urge2surge urge2surge 3 years ago
One of the worst companies I've invested in. Finally dumped it for big loss. I obviously played the fool again. Glta
πŸ‘οΈ0
georgie18 georgie18 3 years ago
AIKI...72...:partying_face:
πŸ‘οΈ0
db101 db101 3 years ago
Get ready for the buttered popcorn...
πŸ‘οΈ0
georgie18 georgie18 3 years ago
AIKI...73...Bullish 3 Gap Downs Reversal Pattern to the Upside on this Oversold Chart...

Psar flipped Bullish...Been accumulating under $1...

Chart https://schrts.co/exhPMSRA ...
πŸ‘οΈ0
White Lightning White Lightning 3 years ago
Looks like good news AlKl

https://apple.news/AnumIdrGsR-CRYxMFTxj-5Q

This should go over a dollar soon here!!!!
πŸ‘οΈ0
TheFinalCD TheFinalCD 3 years ago
AIkido owns 525,000 shares of DatChat, which it previously purchased for $500,000.00. As of September 13th, DatChat shares closed at $6.54, well higher than its IPO price and representing a more than 600% return or an additional $3,433,500.00 added to AIKI balance sheet. $AIKI

https://twitter.com/ohheytommy/status/1448004249493798912
πŸ‘οΈ0
georgie18 georgie18 3 years ago
AIKI...92...on the P/M Gappa...:partying_face:
πŸ‘οΈ0
urge2surge urge2surge 3 years ago
Impressed with the CEO management taking investment stakes in pivotal companies, thereby adding significant value here. Great job IMO.
πŸ‘οΈ0
TGOO TGOO 3 years ago
Interesting, low ss here...
πŸ‘οΈ0
Sirpeter Sirpeter 3 years ago
Very volatile but looks ready
πŸ‘οΈ0
sportd sportd 3 years ago
Added let’s see what this can do
πŸ‘οΈ0
Sirpeter Sirpeter 3 years ago
Kaboom!
πŸ‘οΈ0
Sirpeter Sirpeter 3 years ago
Bullish
πŸ‘οΈ0
antman antman 3 years ago
Would be nice... it has been ages since they did the financing around $1.65 and it began to drop ever since
πŸ‘οΈ0
db101 db101 3 years ago
AIkido Pharma Releases Shareholder Update; Near Term Catalysts Approaching
πŸ‘οΈ0
db101 db101 3 years ago
News...
πŸ‘οΈ0
georgie18 georgie18 3 years ago
AIKI...86...Tue, July 27, 2021, 10:00 AM
AIkido's License to Technology Includes Targeted Psilocybin Treatment for Cancer Patients

NEW YORK, July 27, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for application No.: 16/477,125. This technology relates to the use of novel and proprietary central nervous system (CNS) homing peptides. This technology has been exclusively sublicensed to AIkido Pharma for use of psilocybin for the therapeutic treatment of neuroinflammatory disease in cancer patients.
πŸ‘οΈ0
georgie18 georgie18 3 years ago
AIKI...97...Bounce off the .85 range on the Bullish Engulfing Reversal Candle to the Upside...

Psar flipped to a Bullish Buy Position...as the MACD Crossed to the positive side...

Chart...https://schrts.co/FqVVQIHY ...
πŸ‘οΈ0
wesley_ wesley_ 4 years ago
$1.10 nice
πŸ‘οΈ0
urge2surge urge2surge 4 years ago
No respect from the street on this company. Corporate..how about getting some dignity and respect by actually executing and aggressive communications to the investing arena? Grow a pair..
πŸ‘οΈ0
urge2surge urge2surge 4 years ago
Yeah definitely under substantial book value here. Not just on cash, but potential pipeline, nols, licensing rev's. You buy the dips here and wait on a significant return.
πŸ‘οΈ0
Chess Master Chess Master 4 years ago
BULLISH RESEARCH ARTICLE! Trading under cash and great upside on great results. https://insiderfinancial.com/akido-pharmas-aiki-clinical-trial-results-continues-to-validates-gileads-21-billion-purchase-of-immunomedics/181580/
πŸ‘οΈ0
ClayTrader ClayTrader 4 years ago
* * $AIKI Video Chart 04-21-2021 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0
georgie18 georgie18 4 years ago
AIKI...86...NEW YORK, April 16, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today noted that a recent study announced positive early results from a PSMA 617-Lu177 study conducted by a leading global pharmaceutical company. The report provides strong indications for analogous success in similar technology the Company is helping to develop.

The article can be accessed at:
https://www.thepharmaletter.com/article/further-vindication-for-novartis-in-radioligand-space
πŸ‘οΈ0
georgie18 georgie18 4 years ago
AIKI...$1.20...in the P/M...NEW YORK, April 7, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that it has been granted an exclusive sublicense to technology related to the use of novel and proprietary central nervous system (CNS) homing peptides for the therapeutic treatment of neuroinflammatory disease in cancer patients...

https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1857821
πŸ‘οΈ0
georgie18 georgie18 4 years ago
AIKI...$1.17...Bidding the Lower Band to the 20ma to add to my Core Position...

Looking for the 2 Open Gaps to fill and a $2 Breakout..imo...we shall see....

Chart...https://schrts.co/BrjKBXYy ...
πŸ‘οΈ0
georgie18 georgie18 4 years ago
AIKI...$1.17...in the P/M...https://www.otcmarkets.com/stock/AIKI/news/story?e&id=1849940 ...:party:
πŸ‘οΈ0
Taurus69 Taurus69 4 years ago
$aiki $1.17 ? 0.0 (0.00%)
Volume: 3,920,435 @03/26/21 7:41:58 PM EDT
πŸ‘οΈ0
ClayTrader ClayTrader 4 years ago
* * $AIKI Video Chart 03-24-2021 * *

Link to Video - click here to watch the technical chart video

πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock